Reporting for Data Review Committees

At AmPharm Statistics, we provide industry-leading solutions pertaining to biostatistics reporting for data review committees, Data Monitoring Committees (DMC), and Data Safety Monitoring Boards (DSMBs).  Whether you are forming a new data review committee for a clinical trial or are already part of one in need of reporting and statistical support, we can help.

What is Reporting for Data Review Committees?

A data review committee,  in an ongoing clinical trial, is tasked with reviewing the treatment efficacy (in varying degrees) and patient safety data in an ongoing manner. Biostatistics reporting for data review committees involves the proper interpretation of scientific data that has been gathered from the said processes and presenting it in a complete and statistical sound manner.  Through this interpretation of reports and data statistics, data review committees are able to better advise the sponsors about their ongoing trial or clinical study regarding the continued safety of trial subjects, the scientific merit and validity of the trial, and more.

Why You Need Reporting for Data Review Committees

  • It ensures the proper reporting of safety data and interim analysis results
  • It relays new knowledge about any suspected or unsuspected safety signals in an easy to understand format
  • The reports can provide documentation supporting trial continuation, or termination
  • Biostatistics reporting for data review committees can possibly help you get regulatory approval earlier if interim efficacy analysis are successful
  • … and more!

Why Choose AmPharm Statistics for Reporting for Data Review Committees?

AmPharm Statistics was founded in 1994 and our company has more than 20 years of experience in providing biostatistics reporting for data review committees. Whether you are part of a data review committee in a research institution or government agency, we can help! With our team of highly skilled biostatisticians, you will be able to expedite reporting for your clinical data review projects in a timely and cost-effective manner.

Want to know more about our reporting capabilities for data review committees? Do not hesitate to call us at 844-674-3377 or email us at rmacarthur@researchpharmacy.com.